111 related articles for article (PubMed ID: 20516253)
61. HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway.
Chen HP; Denicola M; Qin X; Zhao Y; Zhang L; Long XL; Zhuang S; Liu PY; Zhao TC
J Cell Biochem; 2011 Nov; 112(11):3246-55. PubMed ID: 21751234
[TBL] [Abstract][Full Text] [Related]
62. Nuclear receptor co-repressor RIP140 regulates diurnal expression of cytochrome P450 2b10 in mouse liver.
Zhao M; Zhao H; Lin L; Wang Y; Chen M; Wu B
Xenobiotica; 2020 Oct; 50(10):1139-1148. PubMed ID: 32238093
[TBL] [Abstract][Full Text] [Related]
63. Application of HC-AFW1 Hepatocarcinoma Cells for Mechanistic Studies: Regulation of Cytochrome P450 2B6 Expression by Dimethyl Sulfoxide and Early Growth Response 1.
Petzuch B; Groll N; Schwarz M; Braeuning A
Drug Metab Dispos; 2015 Nov; 43(11):1727-33. PubMed ID: 26307675
[TBL] [Abstract][Full Text] [Related]
64. Changes in the expression of cytochromes P450 and nuclear receptors in the liver of genetically diabetic db/db mice.
Yoshinari K; Takagi S; Sugatani J; Miwa M
Biol Pharm Bull; 2006 Aug; 29(8):1634-8. PubMed ID: 16880618
[TBL] [Abstract][Full Text] [Related]
65. Property based optimization of δ-lactam HDAC inhibitors for metabolic stability.
Yoon HC; Choi E; Park JE; Cho M; Seo JJ; Oh SJ; Kang JS; Kim HM; Park SK; Lee K; Han G
Bioorg Med Chem Lett; 2010 Nov; 20(22):6808-11. PubMed ID: 20850971
[TBL] [Abstract][Full Text] [Related]
66. Quantitative High-Throughput Luciferase Screening in Identifying CAR Modulators.
Lynch C; Zhao J; Wang H; Xia M
Methods Mol Biol; 2016; 1473():33-42. PubMed ID: 27518621
[TBL] [Abstract][Full Text] [Related]
67. New in vitro tools to study human constitutive androstane receptor (CAR) biology: discovery and comparison of human CAR inverse agonists.
Küblbeck J; Jyrkkärinne J; Molnár F; Kuningas T; Patel J; Windshügel B; Nevalainen T; Laitinen T; Sippl W; Poso A; Honkakoski P
Mol Pharm; 2011 Dec; 8(6):2424-33. PubMed ID: 22044162
[TBL] [Abstract][Full Text] [Related]
68. A CYP2B6-humanized mouse model and its potential applications.
Li L; Zhang QY; Ding X
Drug Metab Pharmacokinet; 2018 Feb; 33(1):2-8. PubMed ID: 29402634
[TBL] [Abstract][Full Text] [Related]
69. Induction of cytochrome P4502B: role of regulatory elements and nuclear receptors.
Pustylnyak VO; Gulyaeva LF; Lyakhovich VV
Biochemistry (Mosc); 2007 Jun; 72(6):608-17. PubMed ID: 17630905
[TBL] [Abstract][Full Text] [Related]
70. HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo.
Segura-Pacheco B; Avalos B; Rangel E; Velazquez D; Cabrera G
Genet Vaccines Ther; 2007 Sep; 5():10. PubMed ID: 17892546
[TBL] [Abstract][Full Text] [Related]
71. Constitutive androstane receptor -null mice are sensitive to the toxic effects of parathion: association with reduced cytochrome p450-mediated parathion metabolism [corrected].
Mota LC; Hernandez JP; Baldwin WS
Drug Metab Dispos; 2010 Sep; 38(9):1582-8. PubMed ID: 20573718
[TBL] [Abstract][Full Text] [Related]
72. Timosaponin AⅢ induces drug-metabolizing enzymes by activating constitutive androstane receptor (CAR)
Hafiz MZ; Pan J; Gao Z; Huo Y; Wang H; Liu W; Yang J
J Biomed Res; 2024 May; ():1-16. PubMed ID: 38817007
[TBL] [Abstract][Full Text] [Related]
73. Identification of new quinic acid derivatives as histone deacetylase inhibitors by fluorescence-based cellular assay.
Son D; Kim CS; Lee KR; Park HJ
Bioorg Med Chem Lett; 2016 May; 26(9):2365-9. PubMed ID: 26996372
[TBL] [Abstract][Full Text] [Related]
74. Novel method for selecting immunosuppressive histone deacetylase (HDAC) inhibitors with minimal thrombocytopenia.
Matsuoka H; Fujimura T; Unami A; Yamada T; Noto T; Takata Y; Yoshizawa K; Mori H; Aramori I; Mutoh S
Biol Pharm Bull; 2008 Feb; 31(2):305-8. PubMed ID: 18239292
[TBL] [Abstract][Full Text] [Related]
75. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase.
Kwon HJ; Owa T; Hassig CA; Shimada J; Schreiber SL
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3356-61. PubMed ID: 9520369
[TBL] [Abstract][Full Text] [Related]
76. Functional constraints on the constitutive androstane receptor inferred from human sequence variation and cross-species comparisons.
Thompson EE; Kuttab-Boulos H; Krasowski MD; Di Rienzo A
Hum Genomics; 2005 Sep; 2(3):168-78. PubMed ID: 16197734
[TBL] [Abstract][Full Text] [Related]
77. Transducin-like enhancer of split 3 regulates proliferation of melanoma cells via histone deacetylase activity.
Ogawa M; Yaginuma T; Nakatomi C; Nakajima T; Tada-Shigeyama Y; Addison WN; Urata M; Matsubara T; Watanabe K; Matsuo K; Sato T; Honda H; Hikiji H; Watanabe S; Kokabu S
Oncotarget; 2019 Jan; 10(3):404-414. PubMed ID: 30719233
[TBL] [Abstract][Full Text] [Related]
78. Enhancement of Transgene Expression by HDAC Inhibitors in Mouse Embryonic Stem Cells.
Kim YE; Park JA; Park SK; Kang HB; Kwon HJ; Lee Y
Dev Reprod; 2013 Dec; 17(4):379-87. PubMed ID: 25949154
[TBL] [Abstract][Full Text] [Related]
79. Analyzing the Effects of HDAC Inhibitors on DNA Damage and Associated Cytotoxicity in Primary Hepatocytes.
Carlsson MJ; Fahrer J
Methods Mol Biol; 2023; 2589():241-252. PubMed ID: 36255629
[TBL] [Abstract][Full Text] [Related]
80. Retraction: Antitumor Effects of a Novel Phenylbutyrate-based Histone Deacetylase Inhibitor, (
Kulp SK; Chen CS; Wang DS; Chen CY; Chen CS
Clin Cancer Res; 2019 May; 25(9):2940. PubMed ID: 31043388
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
